Moreover, two missense SETD2 mutations that impair the enzymatic activity of SETD2 are identified in primary immunodeficiency disorder patients, providing support for the clinical relevance of SETD2 mutations in the development of human primary immunodeficiency.26 Here, SETD2 is linked to inborn error of immunity.